
IceCure Medical Ltd.
ICCM institutional ownership changes in Q1 2026: 4 institutions opened or added positions, 5 trimmed or exited. ICCM (IceCure Medical Ltd.) is held by 6 institutional investors as of Q1 2026. Top institutional shareholders: UBS Group AG ($46,414), HRT Financial LP ($14,000), Geode Capital Management, LLC ($12,176). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 3, 2026 · Insiders Aug 17, 2026 · Activists Mar 27, 2026 · Congress none
Top Holders
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about ICCM
Who owns ICCM?
6 institutional investors held ICCM on March 31, 2026, led by UBS Group AG ($46,414), HRT Financial LP ($14,000) and Geode Capital Management, LLC ($12,176).
How many hedge funds hold ICCM?
6 institutional investors reported ICCM in their 13F filings for the quarter ended March 31, 2026, $88,406 in all.
Are institutions buying or selling ICCM?
Selling, on balance. In Q1 2026, 5 institutions trimmed or exited ICCM and 4 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer